Mylan sold a ₹1,839 crore stake in Biocon through a block deal, attracting strong institutional demand. ICICI Prudential Mutual Fund emerged as the largest buyer, alongside other mutual funds, insurers and foreign investors, highlighting continued confidence in the pharmaceutical company.
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.